[1]
Sedighi, P. et al. 2026. From Genes to Function: Clinical Experience with the Effectiveness and Safety of Risdiplam and Nusinersen in Spinal Muscular Atrophy. Iranian Journal of Child Neurology. 20, 3 (Jun. 2026), 55–61. DOI:https://doi.org/10.22037/ijcn.v20i3.51971.